Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 5/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | KCNA3 | P22001 | 6/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ovalitenone SCHEMBL29598773 | 0.82 | CYP1A1 (1.00) | CYP1A1CYP1B1ABCB1CYP1A2KDM4E | |
| SCHEMBL31707548 | 0.80 | CYP1A1 (0.67) | CYP1A1CYP1B1ABCB1CYP1A2KCNA3 | |
| SCHEMBL900826 | 0.79 | CYP1A1 (1.00) | CYP1A1CYP1B1ABCB1CYP1A2KCNA3 | |
| SCHEMBL29664148 | 0.79 | CYP1A1 (1.00) | CYP1A1CYP1B1ABCB1CYP1A2KCNA3 | |
| SCHEMBL28738857 | 0.75 | CYP1A1 (0.60) | CYP1A1CYP1B1ABCB1KDM4ECYP3A4 | |
| SCHEMBL29639598 | 0.75 | CYP1A1 (0.60) | CYP1A1CYP1B1ABCB1CYP1A2KCNA3 | |
| SCHEMBL2045384 | 0.74 | CYP1A1 (0.63) | CYP1A1CYP1B1ABCB1CYP1A2KCNA3 | |
| SCHEMBL28738867 | 0.72 | CYP1A1 (0.56) | CYP1A1CYP1B1ABCB1CYP1A2KDM4E | |
| SCHEMBL29639600 | 0.72 | CYP1A1 (0.55) | CYP1A1CYP1B1ABCB1CYP1A2KDM4E | |
| SCHEMBL28738865 | 0.72 | CYP1A1 (0.55) | CYP1A1CYP1B1ABCB1CYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099270-A1 | BIODEGRADABLE UV ABSORBERS AND USES THEREOF II | BASF SE (DE) | 2026-05-15 | — | — | WO | claimed |
| EP-4732823-A1 | COSMETIC PREPARATION | Laverana GmbH & Co. KG (DE) | 2026-04-29 | — | — | EP | claimed |
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | TerViva BioEnergy, Inc. (US) | 2026-04-28 | — | — | US | claimed |
| US-20260076366-A1 | SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS | 0903608 B C LTD (CA) | 2026-03-19 | — | — | US | claimed |
| EP-4687823-A1 | COMPOSITION USEFUL FOR SLOWING DOWN DEGRADATION CAUSED BY LIGHT, HEAT AND/OR THE OXIDATION OF AN ACTIVE COMPOUND | Sensient Cosmetic Technologies (FR) | 2026-02-11 | — | — | EP | claimed |
| US-20250367107-A1 | SUNSCREEN COMPOSITION INCLUDING A SALICYLATE AND PONGAMIA PINNATA SEED EXTRACT | EDGEWELL PERSONAL CARE BRANDS LLC (US) | 2025-12-04 | — | — | US | claimed |
| WO-2025242899-A1 | SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF | BASF SE (DE) | 2025-11-27 | — | — | WO | claimed |
| WO-2025242884-A1 | SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF | BASF SE (DE) | 2025-11-27 | — | — | WO | claimed |
| WO-2025242885-A1 | SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF | BASF SE (DE) | 2025-11-27 | — | — | WO | claimed |
| WO-2025242892-A1 | SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF | BASF SE (DE) | 2025-11-27 | — | — | WO | claimed |
| WO-2017013264-A1 | PROCESS FOR PONGAMOL ENRICHMENT OF KARANJA OIL | BIOSYNTHIS (FR) | 2017-01-26 | — | — | WO | claimed |
| WO-2016016540-A2 | SOLAR FILTER PROMOTING AGENTS | INNOVI (FR) | 2016-02-04 | — | — | WO | claimed |
| WO-2014114888-A2 | ALTERNATIVE SYSTEM FOR PROTECTION AGAINST UV RADIATION AND FREE RADICALS | THOREL JEAN-NOëL (FR) | 2014-07-31 | — | — | WO | claimed |
| WO-2012119860-A1 | COSMETIC COMPOSITION CONTAINING A DIBENZOYLMETHANE DERIVATIVE AND A MONOESTER-MONOAMIDE COMPOUND OF METHYLSUCCINIC ACID; PROCESS FOR PHOTOSTABILIZING A DIBENZOYLMETHANE DERIVATIVE | L'OREAL (FR) | 2012-09-13 | — | — | WO | claimed |
| US-20110206789-A1 | HERBAL EXTRACT PRODUCTS AND METHODS (as amended) | PRIME INTERACTION HOLDINGS LIMITED (LI) | 2011-08-25 | — | — | US | claimed |
| WO-2011027362-A2 | A HERBAL ANTI-TERMITE FORMULATION | KUMAR VISHAL (IN) | 2011-03-10 | — | — | WO | claimed |
| EP-0521651-B1 | Sunscreen composition | UNILEVER PLC (GB) | 1996-08-21 | — | — | EP | claimed |
| EP-0431755-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1994-01-26 | — | — | EP | claimed |
| EP-0521651-A2 | Sunscreen composition | UNILEVER PLC (GB) | 1993-01-07 | — | — | EP | claimed |
| EP-0431755-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1991-06-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12610971-B2 | Pongamia compositions, methods of preparing and analyzing thereof, and uses thereof | DEK, DGKG, SRMS | CYP1A1 2801/4885CYP1B1 3735/4885ABCB1 4748/4885 |
| US-20260076366-A1 | SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS | TACR3, GSTO1, TIAL1 | CYP1A1 1148/4885CYP1B1 469/4885ABCB1 1041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.